StockData
Latigo Biotherapeutics, Inc. logo

Latigo Biotherapeutics, Inc. (LTGO) company profile

LTGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026
$13.76+1.16 (+9.21%)

Close on Nov 17, 2026Market cap $912.28MP/E –Yield 0.00%

About Latigo Biotherapeutics

Pharmaceutical Preparations, SIC 2834

Latigo Biotherapeutics, Inc. is listed on Nasdaq under the ticker LTGO, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.

Company profile

Company

Legal name
Latigo Biotherapeutics, Inc.
Headquarters
Thousand Oaks, CA
Address
1300 Rancho Conejo Blvd., Suite 305
Phone
(805) 716-2927
Industry
Pharmaceutical Preparations
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
LTGO
Exchange
Nasdaq
IPO date
Aug 7, 2026
Shares outstanding
66M, Sep 1, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
2056611
CUSIP
517954103
ISIN
US5179541033
FIGI
BBG01LGT3SL3
Share class FIGI
BBG01LGT3SM2
EIN
83-2625838

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Nima FarzanPresident and CEO, Director114,453
Neha KrishnamohanCFO and Chief Business Officer–
Neil SinglaChief Medical Officer–
Todd N. SmithDirector–
Beth C. SeidenbergDirector4,916,374
James B. TananbaumDirector3,117,664
Timothy P. WalbertDirector–
Sara BonsteinDirector–
Kevin RaidyDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Aug 7, 2026
Offer price
$18.00
Securities offered
19,200,000
Gross proceeds
$345.60M
Exchange
Nasdaq
First trading day
Aug 7, 2026
First-day close
$18.25+1.4%
Lock-up ends (est.)
Feb 3, 2027

“The initial public offering price is $18.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?